Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -85,260 | -250,460 | -167,183 | -116,889 | -65,664 |
| Depreciation Amortization | 2,048 | 8,699 | 6,543 | 4,371 | 2,159 |
| Income taxes - deferred | N/A | 34 | N/A | N/A | N/A |
| Accounts receivable | -1,000 | -8,189 | -6,372 | -3,127 | 839 |
| Other Working Capital | -11,855 | -28,938 | -24,552 | -32,576 | -32,520 |
| Other Operating Activity | 37,752 | 76,363 | 59,587 | 39,944 | 22,832 |
| Operating Cash Flow | $-58,315 | $-202,491 | $-131,977 | $-108,277 | $-72,354 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 59,084 | 82,645 | 148,974 | 113,512 | 87,433 |
| PPE Investments | -871 | -3,884 | -2,124 | -1,234 | -868 |
| Investing Cash Flow | $58,213 | $78,761 | $146,850 | $112,278 | $86,565 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -20 | -479 | -460 | -389 | -368 |
| Common Stock Issued | 859 | 229,208 | 227,337 | 25,891 | 23,391 |
| Common Stock Repurchased | -8,993 | -15,009 | -14,700 | -14,438 | -14,194 |
| Other Financing Activity | 0 | -1,647 | 0 | 0 | 0 |
| Financing Cash Flow | $-8,154 | $212,073 | $212,177 | $11,064 | $8,829 |
| Exchange Rate Effect | -3,377 | -5,049 | -4,141 | -1,439 | -1,153 |
| Beginning Cash Position | 249,456 | 166,162 | 166,162 | 166,162 | 166,162 |
| End Cash Position | 237,823 | 249,456 | 389,071 | 179,788 | 188,049 |
| Net Cash Flow | $-11,633 | $83,294 | $222,909 | $13,626 | $21,887 |
| Free Cash Flow | |||||
| Operating Cash Flow | -58,315 | -202,491 | -131,977 | -108,277 | -72,354 |
| Capital Expenditure | -871 | -3,884 | -2,124 | -1,234 | -868 |
| Free Cash Flow | -59,186 | -206,375 | -134,101 | -109,511 | -73,222 |